Both in Pharmaceuticals
Pyxis Oncology vs Yarrow Bioscience
Over the past year PYXS returned −48.3% and YARW returned −44.8%; their daily moves had a correlation of 0.30.
PYXS −48.3% YARW −44.8%Growth of $1, one year, split-adjusted
| Metric | PYXS | YARW |
|---|---|---|
| Price | $1.66 | $14.91 |
| Market cap | $138.5M | $125.8M |
| Today | +1.22% | −18.84% |
| 1 month | −17.8% | −20.4% |
| 6 months | −27.8% | — |
| Year to date | +44.3% | — |
| 1 year | −56.4% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 12.5× | — |
| Net cash | $33.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 95.4% | — |
| Short % of float | 7.9% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).